What are treatment options for Stage Stage IV breast cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Treatment Options for Stage IV (Metastatic) Breast Cancer
Stage IV breast cancer, also called metastatic breast cancer, means the cancer has spread beyond the breast and nearby lymph nodes to other parts of the body. While Stage IV breast cancer is not curable, it is treatable, and many people live for years with good quality of life through ongoing treatment.
Your Treatment Plan Depends on Your Cancer's Biology
According to NCCN Guidelines for Patients: Metastatic Breast Cancer, your treatment options are primarily determined by three important markers in your cancer cells:
- Hormone Receptor (HR) status - whether your cancer has estrogen (ER) or progesterone (PR) receptors
- HER2 status - whether your cancer overexpresses the HER2 protein
- Your overall health and symptoms
Main Treatment Categories
1. HR-Positive, HER2-Negative (HR+/HER2-)
This is the most common subtype. The NCCN Guidelines recommend:
If you don't have a visceral crisis (life-threatening spread to organs):
- Endocrine (hormone) therapy is usually the first choice, often combined with CDK4/6 inhibitors (drugs like palbociclib, ribociclib, or abemaciclib that help hormone therapy work better)
- If you're premenopausal, you may also need ovarian suppression to stop your ovaries from making estrogen
- Options include combinations like letrozole + ribociclib or fulvestrant + palbociclib
If endocrine therapy stops working (called endocrine resistance):
- Chemotherapy may be recommended
- Antibody-drug conjugates (ADCs) - these are targeted drugs that deliver chemotherapy directly to cancer cells
- Other targeted therapies depending on specific mutations
2. HER2-Positive (HER2+)
According to NCCN Guidelines, HER2+ metastatic breast cancer is treated with:
- HER2-targeted therapies such as:
- Trastuzumab (Herceptin) - often combined with chemotherapy or other HER2 drugs
- Pertuzumab (Perjeta) - frequently used with trastuzumab
- T-DM1 (Kadcyla) or T-DXd (Enhertu) - antibody-drug conjugates
- Tucatinib, neratinib, or lapatinib - oral HER2 inhibitors
- These are often combined with chemotherapy initially
- Hormone therapy may be added if your cancer is also HR+
3. Triple-Negative (TNBC)
For cancer that is HR-negative and HER2-negative, the NCCN Guidelines recommend:
- Chemotherapy as the backbone of treatment
- Immunotherapy (pembrolizumab) if your tumor is PD-L1 positive
- PARP inhibitors (olaparib or talazoparib) if you have a BRCA1 or BRCA2 mutation
- Antibody-drug conjugates like sacituzumab govitecan
Additional Treatment Approaches
Local Treatments
The NCCN Guidelines for Patients: Inflammatory Breast Cancer notes that local therapies may include:
- Radiation therapy - to control cancer in specific areas or relieve symptoms
- Surgery - in select cases to remove isolated metastases or for symptom control
Supportive Care
- Bone-strengthening medications (bisphosphonates or denosumab) if cancer has spread to bones
- Pain management
- Palliative care - specialized medical care focused on relief from symptoms and stress (this can be given alongside cancer treatment)
Important Considerations
According to the American Cancer Society, treatment for Stage IV breast cancer is typically ongoing and may change over time as:
- Your cancer responds to treatment or develops resistance
- New symptoms appear
- Your treatment goals evolve
- New treatment options become available through FDA approvals
Next Steps
The NCCN emphasizes that treatment decisions should involve a multidisciplinary team (MDT) - specialists from different areas working together on your care. This team should include:
- Medical oncologist
- Radiation oncologist
- Surgeon (if needed)
- Pathologist
- Radiologist
- Supportive care specialists
Most importantly: Have regular conversations with your care team about your treatment goals, how you're feeling, and what matters most to you. Treatment plans can be adjusted based on how well they're working and how they're affecting your quality of life.
Would you like more specific information about any of these treatment options or help understanding your particular situation?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r